Status:

UNKNOWN

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

Lead Sponsor:

Zhiyong Yu

Conditions:

Breast Cancer

Chemotherapy Effect

Eligibility:

FEMALE

18-70 years

Phase:

PHASE2

PHASE3

Brief Summary

Worldwide, breast cancer is the most incident and prevalent cancer among women. Despite advances in the treatment of advanced breast cancer (ABC) during the past decade, adjuvant systemic therapy has ...

Detailed Description

The trial is designed to help us to choose the maintain treatment regiment for the patients with effective first-line salvage therapy. After inorelbine and gemcitabine (NG) or vinorelbine and platinum...

Eligibility Criteria

Inclusion

  • All patients were required to give written informed consent.
  • Patients with distant metastasis who primary received anthracycline and taxane adjuvant chemotherapy after surgery.
  • After inorelbine and gemcitabine (NG) or vinorelbine and platinum (NP) regiments for 6 cycles,patients were assessed the effect of treatment. As for the patients with complete response (CR), partly response (PR) and stable disease(SD).
  • Have normal cardiac functions by echocardiography
  • ECOG scores are ≤ 0-1.
  • Patients are disposed to practice contraception during the whole trial.
  • The results of patients' blood tests are as follows:
  • Hb ≥ 90 g/L WBC ≥ 3.0×109/L Plt ≥ 100×109/L Neutrophils ≥ 1.5×109/L ALT and AST ≤ 2.5 times of normal upper limit. TBIL ≤ 1.5 times of normal upper limit. Creatinine ≤ 1.5 times of normal upper limit.

Exclusion

  • Have other cancers at the same time or have the history of other cancers in recent five years, excluding the controlled skin basal cell carcinoma or skin squamous cell carcinoma or carcinoma in situ of cervix.
  • Active infections.
  • Severe non-cancerous diseases.

Key Trial Info

Start Date :

February 8 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 8 2020

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03423849

Start Date

February 8 2018

End Date

February 8 2020

Last Update

February 6 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy | DecenTrialz